This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network

Title Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network
Abstract

The EPIC consortium brings together experts from a wide range of fields that include clinical, molecular and basic microbiology, infectious diseases, computational biology and chemistry, drug discovery and design, bioinformatics, biochemistry, biophysics, pharmacology, toxicology, veterinary sciences, environmental sciences, and epidemiology. The main question to be answered by the EPIC alliance is the following: “What is the best approach for data mining on carbapenemase inhibitors and how to translate this data into experiments?” From this forum, we propose that the scientific community think up new strategies to be followed for the discovery of new carbapenemase inhibitors, so that this process is efficient and capable of providing results in the shortest possible time and within acceptable time and economic costs.

Apa Reference Dahdouh, E., Allander, L., Falgenhauer, L., Iorga, B. I., Lorenzetti, S., Marcos-Alcalde, Í., Martin, N. I., Martínez-Martínez, L., Mingorance, J., Naas, T., Rubin, J. E., Spyrakis, F., Tängdén, T., & Gómez-Puertas, P. (2022). Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network. International Journal of Molecular Sciences, 23(17), 9746. 10.3390/ijms23179746
Doi 10.3390/ijms23179746
Publication Date 28 Aug 2022
Publication Type Article
Researcher Paulino Gomez-Puertas
Ontology Drug Discovery and design
Research Groups Molecular Modeling Group
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home